This HTML5 document contains 230 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1182/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n8https://w3id.org/oc/corpus/br/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q24670020
rdf:type
wikibase:Item
schema:description
naučni članak bài báo khoa học vitenskapelig artikkel 2005년 논문 tudományos cikk מאמר אקדמי 2005年学术文章 επιστημονικό άρθρο vitskapeleg artikkel мақолаи илмӣ scienca artikolo 2005年學術文章 article científic 2005 nî lūn-bûn articol științific teaduslik artikkel artykuł naukowy artikulong pang-agham 2005 թվականի հուլիսին հրատարակված գիտական հոդված 2005年学术文章 2005年學術文章 2005年學術文章 наукова стаття, опублікована в липні 2005 мақолаи илмӣ 2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած scientific article article scientific სამეცნიერო სტატია научни чланак (објављен 2005/07/01) 2005年學術文章 wissenschaftlicher Artikel 2005年学术文章 2005年学术文章 научна статия 2005年学术文章 vetenskaplig artikel (publicerad på 2005/07/01) مقالهٔ علمی artículo científico publicado en 2005 artigo científico (publicado na 2005/07/01) article scientifique (publié 2005/07/01) artigo científico wetenschappelijk artikel (gepubliceerd op 2005/07/01) 2005年學術文章 artículu científicu espublizáu en 2005 tieteellinen artikkeli سائنسی مضمون 2005年學術文章 vedecký článok (publikovaný 2005/07/01) artigo científico (publicado na 2005) 2005年の論文 บทความทางวิทยาศาสตร์ articolo scientifico (pubblicato il 2005/07/01) научни чланак mokslinis straipsnis videnskabelig artikel (udgivet 2005/07/01) bilimsel makale artikull shkencor ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالة علمية نشرت في يوليو 2005 حول موضوع: علم الأحياء الخلوي научная статья vědecký článek publikovaný v roce 2005
p:P577
wds:Q24670020-AEB3A153-5CD1-4053-9053-03A7D1E2611D
wdt:P577
2005-03-10T00:00:00Z
p:P407
wds:Q24670020-9D1CD3B9-D6BB-4B57-99FA-8D68B1C16317
wdt:P407
wd:Q1860
p:P2860
wds:Q24670020-074BC047-483E-460C-B584-F983401F83EC wds:Q24670020-085801B2-6372-48FA-BF38-5348C76FFB02 wds:Q24670020-0F98E487-D8D8-4F11-B52A-113C100A07FC wds:Q24670020-ED433290-B421-43C9-9EFD-922EDDCD507F wds:Q24670020-F20932E7-AB14-4AC0-9919-791FFEF67069 wds:Q24670020-F6125E6D-B23A-4333-9F27-AF8258527A09 wds:Q24670020-FA600C3B-C61A-45AA-B3C4-0AD9A5B3BB54 wds:Q24670020-FDC21511-2C4D-46F8-AEA9-B770BC7E418A wds:Q24670020-36C70BD1-A2CC-4477-9BFC-38E464C92B5A wds:Q24670020-3CE51423-5892-4DD4-B40F-7B2F769CA052 wds:Q24670020-441190E9-CAB8-4092-A5CB-E3C230AD23C6 wds:Q24670020-44D7DA1B-934D-44D9-953A-C409C1734E41 wds:Q24670020-201CF601-1C54-48B6-96C5-339F79644C77 wds:Q24670020-22F94FB8-9981-4984-BC59-11A8F8A32C16 wds:Q24670020-25AF708D-2293-48C5-AD17-1A4B7C9A01DE wds:Q24670020-299DC478-0BE4-4EA1-95DD-D2B9500A69B0 wds:Q24670020-6C612EEF-E104-46B8-9E98-EA830C587325 wds:Q24670020-7179B1F5-2545-4D0D-BB2F-350A6CD4A710 wds:Q24670020-779D09D9-A5A3-480F-AA4A-E538385087FF wds:Q24670020-7C7D4710-EEC0-4256-A2A4-D4B7C48AD8A9 wds:Q24670020-7C9C5564-EA64-4D5B-B6C4-0DB4CFCE9CBB wds:Q24670020-5CCE0E12-F916-44DF-8717-0FD299DD16B9 wds:Q24670020-5D02ADA8-EBBC-41E8-9A07-8014B1DDAB7E wds:Q24670020-68DEBF0F-1125-43C6-BF53-B132C5CB3A9A wds:Q24670020-904397B0-6EBD-4DE8-9B3D-11ADAAA677F1 wds:Q24670020-963DAA44-31ED-4E00-A88F-55F7A3D07176 wds:Q24670020-833604CC-E512-42F9-8DCF-934B973DB591 wds:Q24670020-89922BE9-2DA7-4BEB-B0F7-D5621E72FC46 wds:Q24670020-8D38D102-6C81-4E2F-B8A9-DC1C32298D53 wds:Q24670020-BC664F67-BCA8-46FD-9F18-C94FD3582D1E wds:Q24670020-C59EEFF9-0C63-4153-AE44-6B0B852C6BF5 wds:Q24670020-CCB09FE6-8B8A-4988-B27B-C0C210A28403 wds:Q24670020-D4115DAD-B9CC-4172-9652-970943694FC8 wds:Q24670020-D8888321-F8B6-468E-A92B-DD1C4176B02A wds:Q24670020-A802F896-F2B3-4E34-B508-60ADC04D0A8A wds:Q24670020-AAA49C45-FA31-4A81-8437-9A80C271FDD9 wds:Q24670020-AB0ADC77-3632-40E4-A54D-F82FB0A8A548 wds:Q24670020-B82B92FB-4E3E-4724-A65E-74C1DBBB09DD wds:Q24670020-B8F359D4-6E03-4705-B968-40652D47CFA8
wdt:P2860
wd:Q33490333 wd:Q35128648 wd:Q40598509 wd:Q71102200 wd:Q34720507 wd:Q34722375 wd:Q72775904 wd:Q34743741 wd:Q71758981 wd:Q72042570 wd:Q71647324 wd:Q40567164 wd:Q33767874 wd:Q73292530 wd:Q36602827 wd:Q71619513 wd:Q43718516 wd:Q34536382 wd:Q33235500 wd:Q44902366 wd:Q34542232 wd:Q67896951 wd:Q44776802 wd:Q34743618 wd:Q35018629 wd:Q71617612 wd:Q33901588 wd:Q33502338 wd:Q34692984 wd:Q71197371 wd:Q45244768 wd:Q34746700 wd:Q72091094 wd:Q34517235 wd:Q78138559 wd:Q52722390 wd:Q44784443 wd:Q44228586 wd:Q69736957
p:P2093
wds:Q24670020-FFBC10F9-2D50-4BF2-A313-40E9FB116D01 wds:Q24670020-B59979E0-F501-48E9-A67F-9334B5110FEC wds:Q24670020-A7613F9E-23BD-43AB-84F3-491DDBE8376A wds:Q24670020-9FFE9B38-EB07-4C37-8094-CF7397F91112 wds:Q24670020-97DCB7D1-3622-4E15-A350-BDD9105917D5 wds:Q24670020-92CC1448-71DA-4990-AECA-977598F00093 wds:Q24670020-8FAF9C58-37F9-478B-BC93-D316E1F2A1E9 wds:Q24670020-7B7D5803-F65C-46F7-B39F-C8B39114748C wds:Q24670020-4EFB933F-9628-41A7-B985-AF25C70281D9 wds:Q24670020-5A562BFF-142B-41C8-80DC-B0B44CBCB39D wds:Q24670020-36251E01-7B36-4440-BDED-5F1160EFF2AF wds:Q24670020-311B0CE0-25EB-4AD2-AC12-747E3CA96818 wds:Q24670020-31FA40EC-818C-4338-ADBB-8D4CB8BE5B2F wds:Q24670020-300BA692-E992-4A99-8274-310E118A9179 wds:Q24670020-1ACF8256-7B33-460D-8D7A-8F29D1520766
p:P3181
wds:Q24670020-CB83B530-76B9-4D7C-BD98-AB54A7751B5A
wdtn:P3181
n8:2085504
wdt:P2093
EORTC/GIMEMA Leukemia Group Theo De Witte Jean-Pierre Marie Francesco Ricciuti Xavier Thomas Franco Mandelli George Fillet Ulrich Jehn Zwi Berneman Filip Beeldens Francois Lefrère Claudio Denzlinger Roel Willemze Marco Casini Pietro Leoni
wdt:P3181
2085504
rdfs:label
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
skos:prefLabel
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
schema:name
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
p:P50
wds:Q24670020-5D733F5B-5843-4AD3-BE5B-5AAB0567F9E5 wds:Q24670020-7F518D64-89B0-4878-A824-B3B49F6FAA8D wds:Q24670020-27258695-C12B-4757-A10D-E5D8723EFF8C wds:Q24670020-8D83A7B5-77B0-4CEE-BD1B-65E440A690A1 wds:Q24670020-675343AF-E722-42E3-B91C-C7DB2B5E97FA wds:Q24670020-6902E6C8-AFAB-4B9A-B756-F6608AEAE0FF
wdt:P50
wd:Q124077304 wd:Q38322944 wd:Q56724874 wd:Q57553823 wd:Q87993081 wd:Q99568574
p:P1476
wds:Q24670020-81484BD9-E65F-4804-968F-630B4ED6AB65
wdt:P1476
Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
p:P304
wds:Q24670020-E8384234-802E-4242-A5DE-213E98CEDD37
wdt:P304
27-34
p:P31
wds:Q24670020-82D626E9-EDBA-4100-AB0A-95005D0B0E97
wdt:P31
wd:Q13442814
p:P921
wds:Q24670020-09C88908-A6F1-4507-BDA8-936FC6E34986 wds:Q24670020-ED9EFF38-3B7B-4E82-8CD6-3A866E2FF76C wds:Q24670020-7F877A0F-0302-4125-8EBE-AB0F29CA855A wds:Q24670020-E3ABDC63-32E5-4294-831A-94940E7DFB55 wds:Q24670020-478FEA96-3C8C-414B-925C-72C039C3C9D2
wdt:P921
wd:Q29496 wd:Q264118 wd:Q7141 wd:Q974135 wd:Q898365
p:P698
wds:Q24670020-F497C6A1-9584-4255-B36B-8ED3B9E61C3C
wdtn:P698
n13:15761020
wdt:P698
15761020
p:P1433
wds:Q24670020-6962ADE5-E4A9-4F4B-A526-8D4D92736C11
wdt:P1433
wd:Q885070
p:P433
wds:Q24670020-607FBE48-6440-41D7-B42F-5D76E7EE4142
p:P478
wds:Q24670020-1A302F29-372C-479E-A51A-49E0FF47475D
wdt:P433
1
wdt:P478
106
p:P356
wds:Q24670020-78FD9F28-C655-4290-873D-3CF25ED52526
wdtn:P356
n9:BLOOD-2004-09-3728
wdt:P356
10.1182/BLOOD-2004-09-3728
p:P5875
wds:Q24670020-9CF75E29-F166-42DA-B529-2CFE70EF71B5
wdt:P5875
7973475
p:P932
wds:Q24670020-924AF900-3C75-48F9-B12C-2DB129A5645C
wdt:P932
1895135